The Dow Jones Industrial Average is trading down Friday morning with shares of Merck and Amgen seeing the biggest declines for the price-weighted average. Shares of Merck and Amgen are contributing to ...

Which healthcare stock can dividend investors safely buy? Let's consider two excellent options: AbbVie (NYSE: ABBV) and Amgen ...

The Amgen Irish Open has been confirmed in a September date at The K Club as part of the DP World Tour’s 2025 schedule.

TEZSPIRE demonstrated a statistically significant and clinically meaningful reduction in nasal polyp size and reduced nasal congestion compared to placebo ...

(IN BRIEF) A Phase III trial of Tezspire (tezepelumab) by AstraZeneca and Amgen has shown significant benefits for patients ...

(RTTNews) - Amgen Inc. (AMGN) reported earnings for its third quarter that increased from the same period last year and beat the Street estimates. The company's bottom line came in at $2.83 ...

So scientists at Amgen took another route: They developed a drug, Imdelltra, that prompts the immune system’s T cells, which typically kill off cells infected by viruses and other pathogens ...

View upcoming earnings forecasts and in-depth analysis of company forecasts.

Amgen has begun studying a different weight-loss drug candidate, known as AMG513, but few details were disclosed. The company also announced plans for late-stage testing of experimental ...

Amgen is a leading drugmaker -- a business that won't go out of style soon unless scientists discover some magical cure-all. Because that's so unlikely, Amgen is in a great position, and that ...

Amgen Inc.'s Q3 earnings — due 30th October -are unlikely to be a major upside catalyst due to tricky comparisons, increased R&D spending, and transitional phase challenges. Key patents expiring ...

THOUSAND OAKS, Calif., Oct. 25, 2024 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that its Board of Directors declared a $2.25 per share dividend for the fourth quarter of 2024. The ...